maltofer drops
aspen pharmacare australia pty ltd - iron polymaltose, quantity: 185 mg/ml (equivalent: iron, qty 50 mg/ml) - oral liquid - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; purified water; sucrose; sodium hydroxide; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.,prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.
maltofer syrup
aspen pharmacare australia pty ltd - iron polymaltose, quantity: 37 mg/ml (equivalent: iron, qty 10 mg/ml) - oral liquid - excipient ingredients: propyl hydroxybenzoate; purified water; sorbitol solution (70 per cent) (non-crystallising); ethanol; sucrose; sodium hydroxide; methyl hydroxybenzoate; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.
maltofer tablets
aspen pharmacare australia pty ltd - iron polymaltose, quantity: 370 mg (equivalent: iron, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; macrogol 6000; crospovidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; iron oxide yellow; iron oxide red - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.
maltofer tablets
pharmacy retailing (nz) ltd t/a healthcare logistics - iron polymaltose 370mg equivalent to iron 100mg - film coated tablet - 100 mg - active: iron polymaltose 370mg equivalent to iron 100mg excipient: crospovidone macrogol 6000 magnesium stearate microcrystalline cellulose opadry maroon oy-s-36413 - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.
maltofer syrup
pharmacy retailing (nz) ltd t/a healthcare logistics - iron polymaltose 37 mg/ml equivalent to iron 10mg/ml - syrup - 10 mg/ml - active: iron polymaltose 37 mg/ml equivalent to iron 10mg/ml excipient: cream flavour 225082 ethanol methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide sorbitol sucrose - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.
maltofer film-coated tablets 100mg
vifor pharma asia pacific pte. ltd. - iron(iii)-hydroxide polymaltose complex 357mg eqv iron (iii) - tablet, film coated - iron(iii)-hydroxide polymaltose complex 357mg eqv iron (iii) 100mg
maltofer chewable tablet
zuellig pharma sdn bhd - iron -
maltofer syrup
zuellig pharma sdn bhd - iron -
maltofer syrup 50mg5ml
vifor pharma asia pacific pte. ltd. - hydroxide polymaltose complex eqv iron - syrup - 10mg/ml - hydroxide polymaltose complex eqv iron 50mg/5ml
maltofer drops 50 mgml
vifor pharma asia pacific pte. ltd. - iron hydroxide polymaltose eqv iron - solution - 50 mg/ml - iron hydroxide polymaltose eqv iron 50 mg/ml